| European Case Law Identifier: | ECLI:EP:BA:1998:T015397.19981202 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 02 December 1998 | ||||||||
| Case number: | T 0153/97 | ||||||||
| Application number: | 92900942.1 | ||||||||
| IPC class: | A61K 9/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Aerosol Formulation comprising beclomethasone 17,21 Dipropionate | ||||||||
| Applicant name: | Minnesota Mining and Manufacturing Company | ||||||||
| Opponent name: | SkyePharma AG Norton Healthcare Ltd. |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - novelty - no First and second auxiliary request - novelty - yes Inventive step - no - obvious substitution of a component |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970153eu1.html
Date retrieved: 17 May 2021